Uptake and excretion of organochlorine compounds in neonatal calves.
Intestinal absorption mechanisms of young calves change rapidly during the first 24 h postpartum and subsequently effect the absorption efficiencies of a wide range of compounds. This study was conducted to determine absorption efficiencies of (p,p'-dichlorodiphenyl)dichloroethylene (DDE), 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153), and 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin (OCDD) when administered in colostrum to neonatal calves. Four male Holstein calves were given a single oral dose containing 100 mg each of DDE, PCB-153, and OCDD either 1 h (n = 2) or 65 h (n = 2) postpartum to determine whether time of exposure influenced the rate or extent of absorption. Another male calf received 100 mg each of DDE and OCDD 1 h postpartum. One gram of chromic oxide (Cr2O3) was administered as a digestion marker to dosed calves. Two male calves, receiving only colostrum, served as controls. Serum IgG concentrations indicated that the 1-h calves absorbed 20 to 37% of the ingested IgG and 65-h calves < 2%; therefore, the gut absorption mechanisms had changed by 65 h. Plasma DDE, PCB-153, and OCDD profiles did not differ based on time of exposure, suggesting that their mechanism of absorption was not influenced by the changing gut. Trapezoidal area under the curve to the last time point values indicated that, during the trial, relative plasma organochlorine concentrations amounted to PCB-153 > DDE > OCDD. Tissue concentrations were similar across treatment groups, with DDE and PCB-153 residues concentrating in adipose tissue and OCDD in the liver. Absorption efficiencies, calculated from fecal recoveries, were >97%, >74%, and >72% for DDE, PCB-153, and OCDD, respectively. These doses of DDE, PCB-153, and OCDD (2.5 +/- 0.1 mg/kg) did not produce signs of toxicosis based on detailed clinical observations, serum clinical chemistry, and gross and histological observations at necropsy. The results of this study indicate that DDE, PCB-153, and OCDD were absorbed and distributed similarly in calves exposed 1 or 65 h postpartum and did not induce toxicosis when administered in combination at these concentrations.
Keller
H L
HL
The Ohio State University, Ohio Agriculture Research and Development Center, Wooster, 44691-4096, USA.
Borger
D C
DC
Willett
L B
LB
D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D002417:Cattle / Q000378:metabolism*; D002857:Chromium / Q000032:analysis; D003126:Colostrum / Q000737:chemistry; D003633:Dichlorodiphenyl Dichloroethylene / Q000493:pharmacokinetics; D008401:Gas Chromatography-Mass Spectrometry; D007074:Immunoglobulin G / Q000032:analysis; D007306:Insecticides / Q000493:pharmacokinetics*; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D008892:Milk / Q000737:chemistry; D011078:Polychlorinated Biphenyls / Q000493:pharmacokinetics; D000072317:Polychlorinated Dibenzodioxins / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D014018:Tissue Distribution
D007074:Immunoglobulin G; D007306:Insecticides; D000072317:Polychlorinated Dibenzodioxins; D002857:Chromium; D003633:Dichlorodiphenyl Dichloroethylene; D011078:Polychlorinated Biphenyls; C018117:octachlorodibenzo-4-dioxin; C014024:2,4,5,2',4',5'-hexachlorobiphenyl